Number of items: 7.
Collapse authors list.
Griffiths, Gareth, Fitzgerald, Richard, Jaki, Thomas, Corkhill, Andrea, Marwood, Ellice, Reynolds, Helen ORCID: 0000-0001-7443-4520, Stanton, Louise, Ewings, Sean, Condie, Susannah, Wrixon, Emma et al (show 7 more authors) , Norton, Andrea, Radford, Mike, Yeats, Sara, Robertson, Jane, Darby-Dowman, Rachel, Walker, Lauren ORCID: 0000-0002-3827-4387 and Khoo, Saye
(2020)
AGILE-ACCORD: A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19: A structured summary of a study protocol for a randomised platform trial.
TRIALS, 21 (1).
544-.
Collapse authors list.
Griffiths, Gareth O, FitzGerald, Richard, Jaki, Thomas, Corkhill, Andrea, Reynolds, Helen ORCID: 0000-0001-7443-4520, Ewings, Sean, Condie, Susannah, Tilt, Emma, Johnson, Lucy, Radford, Mike et al (show 27 more authors) , Simpson, Catherine, Saunders, Geoffrey, Yeats, Sara, Mozgunov, Pavel, Tansley-Hancock, Olana, Martin, Karen, Downs, Nichola, Eberhart, Izabela, Martin, Jonathan WB, Goncalves, Cristiana, Song, Anna, Fletcher, Tom, Byrne, Kelly, Lalloo, David G ORCID: 0000-0001-7680-2200, Owen, Andrew ORCID: 0000-0002-9819-7651, Jacobs, Michael, Walker, Lauren ORCID: 0000-0002-3827-4387, Lyon, Rebecca, Woods, Christie, Gibney, Jennifer, Chiong, Justin ORCID: 0000-0001-8063-6399, Chandiwana, Nomathemba, Jacob, Shevin, Lamorde, Mohammed, Orrell, Catherine, Pirmohamed, Munir ORCID: 0000-0002-7534-7266 and Khoo, Saye ORCID: 0000-0002-2769-0967
(2021)
AGILE: a seamless phase I/IIa platform for the rapid evaluation of candidates for COVID-19 treatment: an update to the structured summary of a study protocol for a randomised platform trial letter.
TRIALS, 22 (1).
487-.
Collapse authors list.
Khoo, Saye H ORCID: 0000-0002-2769-0967, FitzGerald, Richard, Saunders, Geoffrey, Middleton, Calley, Ahmad, Shazaad, Edwards, Christopher J, Hadjiyiannakis, Dennis, Walker, Lauren ORCID: 0000-0002-3827-4387, Lyon, Rebecca, Shaw, Victoria ORCID: 0000-0002-0429-0186 et al (show 80 more authors) , Mozgunov, Pavel, Periselneris, Jimstan, Woods, Christie, Bullock, Katie ORCID: 0000-0002-5758-0179, Hale, Colin, Reynolds, Helen ORCID: 0000-0001-7443-4520, Downs, Nichola, Ewings, Sean, Buadi, Amanda, Cameron, David, Edwards, Thomas, Knox, Emma, Donovan-Banfield, I'ah ORCID: 0000-0002-5124-2427, Greenhalf, William ORCID: 0000-0002-1865-3195, Chiong, Justin ORCID: 0000-0001-8063-6399, Lavelle-Langham, Lara, Jacobs, Michael, Northey, Josh, Painter, Wendy, Holman, Wayne, Lalloo, David G ORCID: 0000-0001-7680-2200, Tetlow, Michelle, Hiscox, Julian A ORCID: 0000-0002-6582-0275, Jaki, Thomas, Fletcher, Thomas, Griffiths, Gareth, Paton, Nicholas, Hayden, Fred, Darbyshire, Janet, Lucas, Amy, Lorch, Ulrika, Freedman, Andrew, Knight, Richard, Julious, Stevan, Byrne, Rachel, Cubas Atienzar, Ana, Jones, Jayne, Williams, Chris, Song, Anna, Dixon, Jan, Alexandersson, Anja, Hatchard, Parys, Tilt, Emma, Titman, Andrew, Doce Carracedo, Ale ORCID: 0009-0000-1502-0184, Chandran Gorner, Vatsi, Davies, Andrea, Woodhouse, Louis, Carlucci, Nicola, Okenyi, Emmanuel, Bula, Marcin, Dodd, Kate, Gibney, Jennifer, Dry, Lesley, Rashid Gardner, Zalina, Sammour, Amin, Cole, Christine, Rowland, Tim, Tsakiroglu, Maria, Yip, Vincent, Osanlou, Rostam, Stewart, Anna, Parker, Ben, Turgut, Tolga, Ahmed, Afshan, Starkey, Kay, Subin, Sujamole, Stockdale, Jennifer, Herring, Lisa, Baker, Jonathon, Oliver, Abigail, Pacurar, Mihaela, Owens, Dan, Munro, Alistair, Babbage, Gavin, Faust, Saul, Harvey, Matthew, Pratt, Danny, Nagra, Deepak and Vyas, Aashish
(2022)
Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial.
The Lancet Infectious Diseases, 23 (2).
pp. 183-195.
Collapse authors list.
Fennell, Dean A, Ewings, Sean, Ottensmeier, Christian ORCID: 0000-0003-3619-1657, Califano, Raffaele, Hanna, Gerard G, Hill, Kayleigh, Danson, Sarah, Steele, Nicola, Nye, Mavis, Johnson, Lucy et al (show 11 more authors) , Lord, Joanne, Middleton, Calley, Szlosarek, Peter, Chan, Sam, Gaba, Aarti, Darlison, Liz, Wells-Jordan, Peter, Richards, Cathy, Poile, Charlotte, Lester, Jason F and Griffiths, Gareth
(2021)
Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial.
LANCET ONCOLOGY, 22 (11).
pp. 1530-1540.
Collapse authors list.
Walker, Lauren E ORCID: 0000-0002-3827-4387, FitzGerald, Richard, Saunders, Geoffrey, Lyon, Rebecca, Fisher, Michael, Martin, Karen, Eberhart, Izabela, Woods, Christie, Ewings, Sean, Hale, Colin et al (show 23 more authors) , Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Else, Laura, Dilly-Penchala, Sujan, Amara, Alieu ORCID: 0000-0002-1137-2948, Lalloo, David G ORCID: 0000-0001-7680-2200, Jacobs, Michael, Pertinez, Henry, Hatchard, Parys, Waugh, Robert, Lawrence, Megan, Johnson, Lucy, Fines, Keira, Reynolds, Helen ORCID: 0000-0001-7443-4520, Rowland, Timothy, Crook, Rebecca, Okenyi, Emmanuel, Byrne, Kelly, Mozgunov, Pavel, Jaki, Thomas, Khoo, Saye ORCID: 0000-0002-2769-0967, Owen, Andrew ORCID: 0000-0002-9819-7651, Griffiths, Gareth and Fletcher, Thomas E
(2022)
An Open Label, Adaptive, Phase 1 Trial of High-Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS-CoV-2.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 111 (3).
pp. 585-594.
Collapse authors list.
Khoo, Saye H ORCID: 0000-0002-2769-0967, Fitzgerald, Richard, Fletcher, Thomas, Ewings, Sean, Jaki, Thomas, Lyon, Rebecca, Downs, Nichola, Walker, Lauren ORCID: 0000-0002-3827-4387, Tansley-Hancock, Olana, Greenhalf, William et al (show 28 more authors) , Woods, Christie, Reynolds, Helen ORCID: 0000-0001-7443-4520, Marwood, Ellice, Mozgunov, Pavel, Adams, Emily, Bullock, Katie ORCID: 0000-0002-5758-0179, Holman, Wayne, Bula, Marcin D, Gibney, Jennifer L, Saunders, Geoffrey, Corkhill, Andrea, Hale, Colin, Thorne, Kerensa, Chiong, Justin ORCID: 0000-0001-8063-6399, Condie, Susannah, Pertinez, Henry, Painter, Wendy, Wrixon, Emma, Johnson, Lucy, Yeats, Sara, Mallard, Kim, Radford, Mike, Fines, Keira, Shaw, Victoria ORCID: 0000-0002-0429-0186, Owen, Andrew ORCID: 0000-0002-9819-7651, Lalloo, David G ORCID: 0000-0001-7680-2200, Jacobs, Michael and Griffiths, Gareth
(2021)
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 76 (12).
pp. 3286-3295.
Collapse authors list.
FitzGerald, Richard, Dickinson, Laura ORCID: 0000-0001-5557-9396, Else, Laura, Fletcher, Thomas, Hale, Colin, Amara, Alieu ORCID: 0000-0002-1137-2948, Walker, Lauren ORCID: 0000-0002-3827-4387, Penchala, Sujan Dilly, Lyon, Rebecca, Shaw, Victoria ORCID: 0000-0002-0429-0186 et al (show 9 more authors) , Greenhalf, William, Bullock, Katie ORCID: 0000-0002-5758-0179, Lavelle-Langham, Lara, Reynolds, Helen ORCID: 0000-0001-7443-4520, Painter, Wendy, Holman, Wayne, Ewings, Sean, Griffiths, Gareth and Khoo, Saye
(2022)
Pharmacokinetics of ss-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
CLINICAL INFECTIOUS DISEASES, 75 (1).
E525-E528.
This list was generated on Mon Apr 8 12:46:43 2024 BST.